Synonyms: WEHI 164, WEHI164, WEHI 164 TC
WEHI-164 is a mouse fibrosarcoma cell line derived from a tumor induced by subcutaneous injections of 3-methylcholanthrene(1). The model is suitable for efficacy and PD testing of anti-cancer immunotherapeutics in vivo. At CrownBio, the WEHI-164 model is available subcutaneously.
Response to Immune Checkpoint Inhibitors